GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Natus Medical Inc (NAS:NTUS) » Definitions » Operating Margin %

Natus Medical (Natus Medical) Operating Margin % : 5.20% (As of Mar. 2022)


View and export this data going back to 2001. Start your Free Trial

What is Natus Medical Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Natus Medical's Operating Income for the three months ended in Mar. 2022 was $6.2 Mil. Natus Medical's Revenue for the three months ended in Mar. 2022 was $119.8 Mil. Therefore, Natus Medical's Operating Margin % for the quarter that ended in Mar. 2022 was 5.20%.

The historical rank and industry rank for Natus Medical's Operating Margin % or its related term are showing as below:


NTUS's Operating Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.43
* Ranked among companies with meaningful Operating Margin % only.

Natus Medical's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Natus Medical's Operating Income for the three months ended in Mar. 2022 was $6.2 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2022 was $33.0 Mil.


Natus Medical Operating Margin % Historical Data

The historical data trend for Natus Medical's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natus Medical Operating Margin % Chart

Natus Medical Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.92 2.39 5.87 -3.94 6.65

Natus Medical Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.11 5.29 7.63 9.27 5.20

Competitive Comparison of Natus Medical's Operating Margin %

For the Medical Devices subindustry, Natus Medical's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Natus Medical's Operating Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Natus Medical's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Natus Medical's Operating Margin % falls into.



Natus Medical Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Natus Medical's Operating Margin % for the fiscal year that ended in Dec. 2021 is calculated as

Operating Margin %=Operating Income (A: Dec. 2021 ) / Revenue (A: Dec. 2021 )
=31.478 / 473.438
=6.65 %

Natus Medical's Operating Margin % for the quarter that ended in Mar. 2022 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2022 ) / Revenue (Q: Mar. 2022 )
=6.232 / 119.793
=5.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Natus Medical  (NAS:NTUS) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Natus Medical Operating Margin % Related Terms

Thank you for viewing the detailed overview of Natus Medical's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Natus Medical (Natus Medical) Business Description

Traded in Other Exchanges
N/A
Address
3150 Pleasant View Road, Middleton, WI, USA, 53562
Natus Medical Inc is a provider of newborn care, neurology, and hearing and balance assessment healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. It is divided into three business units: Neuro, Newborn Care, and Hearing and Balance. The company generates a majority of its revenue from the Neurology business unit which includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care, and neurosurgery.
Executives
Chung Dong Chune Christopher officer: Vice President Medical Affairs 1501 INDUSTRIAL ROAD SAN CARLOS CA 94070
Bryant M Moore director 181 HARVEST LANE PITTSBORO NC 27312
Eric Guerin director 1950 HASSELL ROAD, HOFFMAN ESTATES IL 60169
Ilan Daskal director 1000 ALFRED NOBEL DRIVE, HERCULES CA 94547
Alice D. Schroeder director 1573 MALLORY LANE, SUITE 100, BRENTWOOD TN 37027
Lisa Wipperman Heine director 1244 76TH STREET WEST, INVER GROVE HEIGHTS MN 55077
Jonathan Kennedy director, officer: Sr. VP, CFO INTERSIL CORPORATION, 1001 MURPHY RANCH ROAD, MILPITAS CA 95035
Ken Ludlum director
Robert A Gunst director
Noll Austin Francis Iii officer: VP/GM Neurology 9805 FALLEN LEAF DRIVE MIDDLETON WI 53562
Thomas Joseph Sullivan director 64 PETTIT PL PRINCETON NJ 08540
Benjamin Drew Davies officer: Sr. VP, CFO 1501 INDUSTRIAL ROAD, SAN CARLOS X1 94070
Joshua Levine director 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Sharon Villaverde officer: Interim CFO 11780 U.S. HIGHWAY 1, SUITE 600, PALM BEACH GARDENS FL 33408
William M Moore director